Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal.
D000470:Alkaloids / Q000378:metabolism; D000818:Animals; D001392:Azocines / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D002540:Cerebral Cortex / Q000187:drug effects / Q000378:metabolism; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D005260:Female; D008297:Male; D026901:Membrane Transport Proteins / Q000378:metabolism; D008636:Mesencephalon / Q000187:drug effects / Q000378:metabolism; D009538:Nicotine / Q000494:pharmacology*; D018722:Nicotinic Agonists / Q000494:pharmacology*; D010275:Parasympathetic Nervous System / Q000187:drug effects*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011807:Quinolizines / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D017661:Receptors, Presynaptic / Q000187:drug effects; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control*; D000093843:Quinolizidine Alkaloids
D000470:Alkaloids; D001392:Azocines; D002795:Choline O-Acetyltransferase; D026901:Membrane Transport Proteins; D009538:Nicotine; D018722:Nicotinic Agonists; D011807:Quinolizines; D017661:Receptors, Presynaptic; C065637:choline transporter; C004712:cytisine; D000093843:Quinolizidine Alkaloids